GlaxoSmithKline will record a legal charge of 2.2 billion pounds ($3.4 billion) for the fourth quarter, effectively wiping out its profit, as it settles further claims related to Avandia and sales practices. Full story
After a long-running controversy about Avandia's heart attack risk, the FDA put such tight restrictions on it that sales in this country are expected to plunge to nearly zero. Meanwhile, regulators in Europe say Avandia will no longer be available at all. NBC's Brian Williams reports.
OIL, Anne Thompson; DICK CHENEY, Jamie Gangel, Robert Bazell; AVANDIA, Robert Bazell; TOYOTA, Brian Williams; ECONOMY, Brian Williams; KANDAHAR ATTACK, Jim Maceda; TEXTING/PARENTING, Kevin Tibbles; VERNON BAKER 1919-2010, Brian Williams; SPIRIT/TSA, Brian Williams; CHICKEN AND EGG, Brian Williams; M
MIAMI - JULY 14: A bottle and pills of the diabetes drug, Avandia are seen on July 14, 2010 in Miami, Florida. European and American drug regulators announced September 23, 2010, that sales of GlaxoSmithKline PLC's diabetes drug, Avandia, will be heavily restricted in the United States and complet